Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Since 12/18/07

Since 12/18/07

posted on Jan 25, 2008 08:35AM

Since 12/18/07 the biggest event in company history and this is all the company has to say??????

2007-12-18
Note Regarding Settlement from CEO Jim Turley

Shareholders are advised that the following is the only information that will be provided by Patriot Scientific Corporation regarding the resolution of the Texas (and California) litigation that had been pending regarding the MMP portfolio patents subject to the dispute:

Patriot Scientific Corporation, its directors, officers and employees are obligated to observe the confidentiality provisions of the settlements and will limit any comments or statements solely to references to the wording of the joint press release or statements that matters between the parties to the litigation have been settled.

 

Verigy Purchases Microprocessor Patent Portfolio License

"Verigy occupies an important position in the overall semiconductor industry," said Jim Turley, president and CEO of Patriot Scientific. "As chips get more complex, it becomes harder to verify they work properly, and Verigy's 1500+ employees make sure that our industry runs smoothly."

 

Humax Licenses Microprocessor Patent Portfolio

In just the first week of 2008, we’re proud to welcome Humax to the long and distinguished roster of MMP licensees," said Jim Turley, president and CEO of Patriot Scientific. "The company’s products are ubiquitous and user-friendly, and I like to think that our technology played a part in that success."

Psion Purchases Microprocessor Patent Portfolio License

"I remember Psion as an early innovator with handheld devices, modems, and software," said Jim Turley, Patriot’s president and CEO. "The company has obviously come a long way since then and it's great to see they’re still at the cutting edge."

Share
New Message
Please login to post a reply